Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 ...

Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis ... Poorer survival in stage IB lung cancer patients after pneumonectomy.

由 X Yang 著作 · 2024 — Background. This study aimed to investigate whether patients with stage IB NSCLC could benefit from adjuvant chemotherapy.

由 X Wang 著作 · 2021 · 被引用 8 次 — Adjuvant chemotherapy (ACT) is routinely the recommended treatment for patients with advanced non-small cell lung cancer (NSCLC) but remains a ...

由 J Choi 著作 · 2022 · 被引用 13 次 — We have shown that adjuvant chemotherapy prolongs RFS and OS in stage IB NSCLC with high-risk factors. Among the various high-risk factors, adjuvant ...

由 Y Xu 著作 · 2022 · 被引用 14 次 — Conclusions: Adjuvant chemotherapy is associated with improved survival in 8th edition stage IB NSCLC patients, especially in those with old age ...

由 HJ Park 著作 · 2018 · 被引用 30 次 — Conclusions: Adjuvant chemotherapy does not affect the prognosis of stage IB NSCLC, even in high-risk patients. Additionally, VPI is a strong prognostic factor ...

由 F Passiglia 著作 · 2023 — On this basis, the international lung cancer guidelines currently do not recommend any adjuvant chemotherapy for surgically resected patients ...

由 M Casiraghi 著作 · 2023 — The Cancer and Leukemia Group B 9633 study showed that adjuvant chemotherapy improved survival in patients with tumors larger than 4 cm in size, ...